The Enterprise Value as of December 2025 (TTM) for Keymed Biosciences Inc. (2162.HK) is 14.72B

According to Keymed Biosciences Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 14.72B. This represents a change of 55.04% compared to the average of 9.50B of the last 4 quarters.

Keymed Biosciences Inc. (2162.HK) Historical Enterprise Value (quarterly & annually)

How has 2162.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Keymed Biosciences Inc. over the last ten years is 10.29B. The current 14.72B Enterprise Value has changed 14.21% with respect to the historical average. Over the past ten years (40 quarters), 2162.HK's Enterprise Value was at its highest in in the December 2019 quarter at 16.11B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Keymed Biosciences Inc. (2162.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Keymed Biosciences Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Keymed Biosciences Inc. (2162.HK) Average Enterprise Value

How has 2162.HK Enterprise Value performed in the past?

The current Enterprise Value of Keymed Biosciences Inc. (2162.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Keymed Biosciences Inc. (2162.HK) Enterprise Value vs. Peers

How is 2162.HK’s Enterprise Value compared to its peers?

Keymed Biosciences Inc.’s Enterprise Value is less than Everest Medicines Limited (15.08B), greater than InnoCare Pharma Limited (12.67B), greater than Guangzhou Innogen Pharmaceutl Grp Co Ltd (14.69B), greater than Zai Lab Limited (1.43B), greater than Lepu Biopharma Co., Ltd. (9.31B), less than Ascentage Pharma Group International (19.01B), greater than CanSino Biologics Inc. (11.92B), less than Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (16.02B), greater than HUTCHMED (China) Limited (1.03B), less than Nanjing Leads Biolabs Co Ltd (0),

Build a custom stock screener for Keymed Biosciences Inc. (2162.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Keymed Biosciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Keymed Biosciences Inc. (2162.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Keymed Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.